Back
Immunovant Vs. Perspective Therapeutics Industry Stock Comparison
Sell
33
IMVT
Immunovant
Last Price:
31.48
Seasonality Move:
10.57%
Buy
62
CATX
Perspective Therapeutics
Last Price:
1.54
Seasonality Move:
2.36%
Sell
33
Immunovant (IMVT)
is a Sell
Is Immunovant a Buy, Sell or Hold?
- The current Immunovant [IMVT] share price is $30.93. The Score for IMVT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- IMVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.57. The Score for CATX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IMVT Stock Price Chart
What is Immunovant's stock price today?
-
The Immunovant share price today is $30.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMVT is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.57
The current trend is moderately bearish and CATX is experiencing slight selling pressure.
IMVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 59.69 | Buy |
| Chaikin Money Flow: | -381083 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.06 - 30.14) | Buy |
| Bollinger Bands (100): | (29.74 - 39.34) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 46.54 | Sell |
| Chaikin Money Flow: | -2625462 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.51 - 1.77) | Sell |
| Bollinger Bands (100): | (0.63 - 1.51) | Buy |
IMVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.93 | Buy |
| 20-day SMA: | 28.91 | Buy |
| 50-day SMA: | 30.31 | Buy |
| 200-day SMA: | 32.6 | Sell |
| 8-day EMA: | 29.93 | Buy |
| 20-day EMA: | 29.59 | Buy |
| 50-day EMA: | 30.82 | Buy |
| 200-day EMA: | 30.86 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.76 | Sell |
| 20-day SMA: | 1.68 | Sell |
| 50-day SMA: | 1.44 | Buy |
| 200-day SMA: | 0.7 | Buy |
| 8-day EMA: | 1.71 | Sell |
| 20-day EMA: | 1.67 | Sell |
| 50-day EMA: | 1.45 | Buy |
| 200-day EMA: | 0.89 | Buy |
Immunovant Earnings Growth & IMVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.09 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Immunovant Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||